The 36-month beta value for ALHC is also noteworthy at 1.21. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for ALHC is 131.13M, and at present, short sellers hold a 7.44% of that float. The average trading volume of ALHC on June 25, 2025 was 3.40M shares.
ALHC) stock’s latest price update
The stock of Alignment Healthcare Inc (NASDAQ: ALHC) has increased by 2185706 when compared to last closing price of 13.97. Despite this, the company has experienced a -2.90% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-10 that ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025.
ALHC’s Market Performance
Alignment Healthcare Inc (ALHC) has experienced a -2.90% fall in stock performance for the past week, with a -2.83% drop in the past month, and a -19.36% drop in the past quarter. The volatility ratio for the week is 1.70%, and the volatility levels for the past 30 days are at 2.35% for ALHC. The simple moving average for the last 20 days is -5.07% for ALHC stock, with a simple moving average of 1.19% for the last 200 days.
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.
ALHC Trading at -11.49% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.14% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from KAO JOHN E, who sale 90,000 shares at the price of $14.48 back on Jun 16 ’25. After this action, KAO JOHN E now owns 1,733,100 shares of Alignment Healthcare Inc, valued at $1,302,849 using the latest closing price.
Maroney Dawn Christine, the President of Alignment Healthcare Inc, sale 30,000 shares at $14.48 during a trade that took place back on Jun 16 ’25, which means that Maroney Dawn Christine is holding 2,072,899 shares at $434,280 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.12 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.03. The total capital return value is set at -0.15. Equity return is now at value -75.82, with -11.86 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 7.53. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -2.98.
Currently, EBITDA for the company is -77.59 million with net debt to EBITDA at 10.9. When we switch over and look at the enterprise to sales, we see a ratio of 0.78. The receivables turnover for the company is 14.02for trailing twelve months and the total asset turnover is 3.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.69.
Conclusion
In summary, Alignment Healthcare Inc (ALHC) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
